Skip to main content

Table 1 Trend in cancer prevalence in term of number of cases and crude rates per 100′000 in Switzerland between 1990 and 2010

From: Cancer survivors in Switzerland: a rapidly growing population to care for

  Prevalence
  Number of persons Rates per 100'000
  1990 2010 Increase [95%CI*] 1990 2010 Increase [95%CI*]
Gender         
  Men 56′201 132′330 +136% [132%-141%] 1′714.5 3′436.2 +101% [ 94%-108%]
  Women 83′516 157′467 +89% [ 85%- 92%] 2′431.8 3′962.6 +63% [ 60%- 66%]
  Total 139′717 289′797 +108% [105%-111%] 2′081.5 3′703.5 +78% [ 74%- 83%]
Time since diagnosis         
  < 1 year 18′113 28′029 +55% [ 51%- 60%] 269.8 417.6 +55% [ 51%- 60%]
  1-4 years 43′759 80′340 +84% [ 76%- 93%] 651.9 1′196.9 +84% [ 76%- 93%]
  5-9 years 30′235 69′368 +129% [118%-141%] 450.4 1′033.5 +129% [118%-140%]
  10-19 years 29′844 69′481 +133% [123%-143%] 444.6 1′035.1 +133% [123%-143%]
  20+ years 17′765 42′578 +140% [135%-145%] 264.7 634.3 +140% [134%-145%]
  Total 139′717 289′797 +108% [105%-111%] 2′081.5 3′703.5 +78% [ 74%- 83%]
Cancer type**         
  Breast 30′892 66′513 +115% [111%-119%] 460.2 850.0 +85% [ 78%- 92%]
  Prostate 12′012 45′421 +279% [267%-291%] 179.0 580.5 +225% [212%-239%]
  Colorectal 16′186 28′567 +77% [ 74%- 79%] 241.1 365.1 +52% [ 49%- 55%]
  Lung 4′689 7′833 +67% [ 55%- 79%] 69.9 100.1 +44% [ 36%- 53%]
  Lymph./Leukaemia 13′470 26′086 +94% [ 92%- 96%] 200.7 333.4 +67% [ 57%- 78%]
  Melanoma 8′367 23′743 +184% [177%-191%] 124.6 303.4 +143% [140%-147%]
  Other 54′102 91′634 +70% [ 66%- 73%] 806.0 1′171.1 +46% [ 40%- 51%]
  Total 139′717 289′797 +108% [105%-111%] 2′081.5 3′703.5 +78% [ 74%- 83%]
Age group         
  0-14 740 1′061 +44% [ 32%- 57%] 64.5 89.7 +40% [ 31%- 49%]
  15-49 21′192 36′285 +72% [ 59%- 86%] 605.3 951.1 +57% [ 56%- 59%]
  50-69 53′236 112′657 +112% [110%-114%] 3′848.7 5′949.8 +54% [ 51%- 58%]
  70-79 37′565 77′033 +106% [ 95%-118%] 8′665.2 13′823.2 +60% [ 54%- 67%]
  80+ 26′984 62′761 +132% [112%-154%] 10′925.9 16′691.0 +53% [ 47%- 60%]
  Total 139′717 289′797 +108% [105%-111%] 2′081.5 3′703.5 +78% [ 74%- 83%]
  1. *CI Confidence Interval.
  2. **Excluding non-invasive and non-melanoma skin cancers.